Global Brucellosis Vaccines Supply, Demand and Key Producers, 2026-2032

January 2026 | 145 pages | ID: G4B78E97EF8FEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Brucellosis Vaccines market size is expected to reach $ 16.07 million by 2032, rising at a market growth of 3.6% CAGR during the forecast period (2026-2032).

Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.

Global Brucellosis Vaccines main players are Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, etc. Global top four manufacturers hold a share above 35%. China is the largest market, with a share about 30%.

This report studies the global Brucellosis Vaccines production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Brucellosis Vaccines and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Brucellosis Vaccines that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Brucellosis Vaccines total production and demand, 2021-2032, (M Doses)

Global Brucellosis Vaccines total production value, 2021-2032, (USD Million)
Global Brucellosis Vaccines production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Doses), (based on production site)
Global Brucellosis Vaccines consumption by region & country, CAGR, 2021-2032 & (M Doses)
U.S. VS China: Brucellosis Vaccines domestic production, consumption, key domestic manufacturers and share
Global Brucellosis Vaccines production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Doses)

Global Brucellosis Vaccines production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)

Global Brucellosis Vaccines production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)

This report profiles key players in the global Brucellosis Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, Vetal Company, CZ Veterinaria, SYVA Laboratorios, Indian Immunologicals, Qilu, Tecnovax, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Brucellosis Vaccines market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (USD/K Doses) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Brucellosis Vaccines Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Brucellosis Vaccines Market, Segmentation by Type:
  • S19 Vaccine
  • RB51 Vaccine Strain
Global Brucellosis Vaccines Market, Segmentation by Application:
  • Cattle
  • Sheep
  • Others
Companies Profiled:
  • Jinyu
  • Colorado Serum
  • Boehringer Ingelheim
  • Biogenesis-Bago
  • Vetal Company
  • CZ Veterinaria
  • SYVA Laboratorios
  • Indian Immunologicals
  • Qilu
  • Tecnovax
  • Hester Biosciences
  • Zoetis
  • Onderstepoort Biological
  • Instituto Rosenbusch
  • Ceva Sante Animale
  • Calier & Biologicos Laverlam
  • Biovet
Key Questions Answered:
1. How big is the global Brucellosis Vaccines market?
2. What is the demand of the global Brucellosis Vaccines market?
3. What is the year over year growth of the global Brucellosis Vaccines market?
4. What is the production and production value of the global Brucellosis Vaccines market?
5. Who are the key producers in the global Brucellosis Vaccines market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 SCADA Introduction
1.2 World SCADA Market Size & Forecast (2021 & 2025 & 2032)
1.3 World SCADA Total Market by Region (by Headquarter Location)
  1.3.1 World SCADA Market Size by Region (2021-2032), (by Headquarter Location)
  1.3.2 United States Based Company SCADA Revenue (2021-2032)
  1.3.3 China Based Company SCADA Revenue (2021-2032)
  1.3.4 Europe Based Company SCADA Revenue (2021-2032)
  1.3.5 Japan Based Company SCADA Revenue (2021-2032)
  1.3.6 South Korea Based Company SCADA Revenue (2021-2032)
  1.3.7 ASEAN Based Company SCADA Revenue (2021-2032)
  1.3.8 India Based Company SCADA Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 SCADA Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Major Market Trends

2 DEMAND SUMMARY

2.1 World SCADA Consumption Value (2021-2032)
2.2 World SCADA Consumption Value by Region
  2.2.1 World SCADA Consumption Value by Region (2021-2026)
  2.2.2 World SCADA Consumption Value Forecast by Region (2027-2032)
2.3 United States SCADA Consumption Value (2021-2032)
2.4 China SCADA Consumption Value (2021-2032)
2.5 Europe SCADA Consumption Value (2021-2032)
2.6 Japan SCADA Consumption Value (2021-2032)
2.7 South Korea SCADA Consumption Value (2021-2032)
2.8 ASEAN SCADA Consumption Value (2021-2032)
2.9 India SCADA Consumption Value (2021-2032)

3 WORLD SCADA COMPANIES COMPETITIVE ANALYSIS

3.1 World SCADA Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global SCADA Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for SCADA in 2025
  3.2.3 Global Concentration Ratios (CR8) for SCADA in 2025
3.3 SCADA Company Evaluation Quadrant
3.4 SCADA Market: Overall Company Footprint Analysis
  3.4.1 SCADA Market: Region Footprint
  3.4.2 SCADA Market: Company Product Type Footprint
  3.4.3 SCADA Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: SCADA Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: SCADA Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  4.1.2 United States VS China: SCADA Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: SCADA Consumption Value Comparison
  4.2.1 United States VS China: SCADA Consumption Value Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: SCADA Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based SCADA Companies and Market Share, 2021-2026
  4.3.1 United States Based SCADA Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies SCADA Revenue, (2021-2026)
4.4 China Based Companies SCADA Revenue and Market Share, 2021-2026
  4.4.1 China Based SCADA Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies SCADA Revenue, (2021-2026)
4.5 Rest of World Based SCADA Companies and Market Share, 2021-2026
  4.5.1 Rest of World Based SCADA Companies, Headquarters (Province, Country)
  4.5.2 Rest of World Based Companies SCADA Revenue (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World SCADA Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 Hardware
  5.2.2 Software
  5.2.3 Services
5.3 Market Segment by Type
  5.3.1 World SCADA Market Size by Type (2021-2026)
  5.3.2 World SCADA Market Size by Type (2027-2032)
  5.3.3 World SCADA Market Size Market Share by Type (2027-2032)

6 MARKET ANALYSIS BY APPLICATION

6.1 World SCADA Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
  6.2.1 Power & Energy
  6.2.2 Oil & Gas Industry
  6.2.3 Water & Waste Control
  6.2.4 Telecommunications
  6.2.5 Transportation
  6.2.6 Manufacturing Industry
  6.2.7 Others
6.3 Market Segment by Application
  6.3.1 World SCADA Market Size by Application (2021-2026)
  6.3.2 World SCADA Market Size by Application (2027-2032)
  6.3.3 World SCADA Market Size Market Share by Application (2021-2032)

7 COMPANY PROFILES

7.1 Schneider Electric SE (France)
  7.1.1 Schneider Electric SE (France) Details
  7.1.2 Schneider Electric SE (France) Major Business
  7.1.3 Schneider Electric SE (France) SCADA Product and Services
  7.1.4 Schneider Electric SE (France) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.1.5 Schneider Electric SE (France) Recent Developments/Updates
  7.1.6 Schneider Electric SE (France) Competitive Strengths & Weaknesses
7.2 ABB (Switzerland)
  7.2.1 ABB (Switzerland) Details
  7.2.2 ABB (Switzerland) Major Business
  7.2.3 ABB (Switzerland) SCADA Product and Services
  7.2.4 ABB (Switzerland) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.2.5 ABB (Switzerland) Recent Developments/Updates
  7.2.6 ABB (Switzerland) Competitive Strengths & Weaknesses
7.3 Siemens AG (Germany)
  7.3.1 Siemens AG (Germany) Details
  7.3.2 Siemens AG (Germany) Major Business
  7.3.3 Siemens AG (Germany) SCADA Product and Services
  7.3.4 Siemens AG (Germany) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.3.5 Siemens AG (Germany) Recent Developments/Updates
  7.3.6 Siemens AG (Germany) Competitive Strengths & Weaknesses
7.4 Emerson (US)
  7.4.1 Emerson (US) Details
  7.4.2 Emerson (US) Major Business
  7.4.3 Emerson (US) SCADA Product and Services
  7.4.4 Emerson (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.4.5 Emerson (US) Recent Developments/Updates
  7.4.6 Emerson (US) Competitive Strengths & Weaknesses
7.5 Rockwell Automation Inc. (US)
  7.5.1 Rockwell Automation Inc. (US) Details
  7.5.2 Rockwell Automation Inc. (US) Major Business
  7.5.3 Rockwell Automation Inc. (US) SCADA Product and Services
  7.5.4 Rockwell Automation Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.5.5 Rockwell Automation Inc. (US) Recent Developments/Updates
  7.5.6 Rockwell Automation Inc. (US) Competitive Strengths & Weaknesses
7.6 Honeywell International Inc. (US)
  7.6.1 Honeywell International Inc. (US) Details
  7.6.2 Honeywell International Inc. (US) Major Business
  7.6.3 Honeywell International Inc. (US) SCADA Product and Services
  7.6.4 Honeywell International Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.6.5 Honeywell International Inc. (US) Recent Developments/Updates
  7.6.6 Honeywell International Inc. (US) Competitive Strengths & Weaknesses
7.7 Mitsubishi Electric (Japan)
  7.7.1 Mitsubishi Electric (Japan) Details
  7.7.2 Mitsubishi Electric (Japan) Major Business
  7.7.3 Mitsubishi Electric (Japan) SCADA Product and Services
  7.7.4 Mitsubishi Electric (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.7.5 Mitsubishi Electric (Japan) Recent Developments/Updates
  7.7.6 Mitsubishi Electric (Japan) Competitive Strengths & Weaknesses
7.8 Omron Corporation (Japan)
  7.8.1 Omron Corporation (Japan) Details
  7.8.2 Omron Corporation (Japan) Major Business
  7.8.3 Omron Corporation (Japan) SCADA Product and Services
  7.8.4 Omron Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.8.5 Omron Corporation (Japan) Recent Developments/Updates
  7.8.6 Omron Corporation (Japan) Competitive Strengths & Weaknesses
7.9 General Electric Co. (US)
  7.9.1 General Electric Co. (US) Details
  7.9.2 General Electric Co. (US) Major Business
  7.9.3 General Electric Co. (US) SCADA Product and Services
  7.9.4 General Electric Co. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.9.5 General Electric Co. (US) Recent Developments/Updates
  7.9.6 General Electric Co. (US) Competitive Strengths & Weaknesses
7.10 Yokogawa Electric Corporation (Japan)
  7.10.1 Yokogawa Electric Corporation (Japan) Details
  7.10.2 Yokogawa Electric Corporation (Japan) Major Business
  7.10.3 Yokogawa Electric Corporation (Japan) SCADA Product and Services
  7.10.4 Yokogawa Electric Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.10.5 Yokogawa Electric Corporation (Japan) Recent Developments/Updates
  7.10.6 Yokogawa Electric Corporation (Japan) Competitive Strengths & Weaknesses
7.11 Larsen & Toubro (India)
  7.11.1 Larsen & Toubro (India) Details
  7.11.2 Larsen & Toubro (India) Major Business
  7.11.3 Larsen & Toubro (India) SCADA Product and Services
  7.11.4 Larsen & Toubro (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.11.5 Larsen & Toubro (India) Recent Developments/Updates
  7.11.6 Larsen & Toubro (India) Competitive Strengths & Weaknesses
7.12 M.B. Control & Systems Pvt. Ltd (India)
  7.12.1 M.B. Control & Systems Pvt. Ltd (India) Details
  7.12.2 M.B. Control & Systems Pvt. Ltd (India) Major Business
  7.12.3 M.B. Control & Systems Pvt. Ltd (India) SCADA Product and Services
  7.12.4 M.B. Control & Systems Pvt. Ltd (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
  7.12.5 M.B. Control & Systems Pvt. Ltd (India) Recent Developments/Updates
  7.12.6 M.B. Control & Systems Pvt. Ltd (India) Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 SCADA Industry Chain
8.2 SCADA Upstream Analysis
8.3 SCADA Midstream Analysis
8.4 SCADA Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES

Table 1. World Brucellosis Vaccines Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Brucellosis Vaccines Production Value by Region (2021-2026) & (USD Million)
Table 3. World Brucellosis Vaccines Production Value by Region (2027-2032) & (USD Million)
Table 4. World Brucellosis Vaccines Production Value Market Share by Region (2021-2026)
Table 5. World Brucellosis Vaccines Production Value Market Share by Region (2027-2032)
Table 6. World Brucellosis Vaccines Production by Region (2021-2026) & (M Doses)
Table 7. World Brucellosis Vaccines Production by Region (2027-2032) & (M Doses)
Table 8. World Brucellosis Vaccines Production Market Share by Region (2021-2026)
Table 9. World Brucellosis Vaccines Production Market Share by Region (2027-2032)
Table 10. World Brucellosis Vaccines Average Price by Region (2021-2026) & (USD/K Doses)
Table 11. World Brucellosis Vaccines Average Price by Region (2027-2032) & (USD/K Doses)
Table 12. Brucellosis Vaccines Major Market Trends
Table 13. World Brucellosis Vaccines Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Doses)
Table 14. World Brucellosis Vaccines Consumption by Region (2021-2026) & (M Doses)
Table 15. World Brucellosis Vaccines Consumption Forecast by Region (2027-2032) & (M Doses)
Table 16. World Brucellosis Vaccines Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Brucellosis Vaccines Producers in 2025
Table 18. World Brucellosis Vaccines Production by Manufacturer (2021-2026) & (M Doses)
Table 19. Production Market Share of Key Brucellosis Vaccines Producers in 2025
Table 20. World Brucellosis Vaccines Average Price by Manufacturer (2021-2026) & (USD/K Doses)
Table 21. Global Brucellosis Vaccines Company Evaluation Quadrant
Table 22. World Brucellosis Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Brucellosis Vaccines Production Site of Key Manufacturer
Table 24. Brucellosis Vaccines Market: Company Product Type Footprint
Table 25. Brucellosis Vaccines Market: Company Product Application Footprint
Table 26. Brucellosis Vaccines Competitive Factors
Table 27. Brucellosis Vaccines New Entrant and Capacity Expansion Plans
Table 28. Brucellosis Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China Brucellosis Vaccines Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Brucellosis Vaccines Production Comparison, (2021 & 2025 & 2032) & (M Doses)
Table 31. United States VS China Brucellosis Vaccines Consumption Comparison, (2021 & 2025 & 2032) & (M Doses)
Table 32. United States Based Brucellosis Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Brucellosis Vaccines Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Brucellosis Vaccines Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Brucellosis Vaccines Production (2021-2026) & (M Doses)
Table 36. United States Based Manufacturers Brucellosis Vaccines Production Market Share (2021-2026)
Table 37. China Based Brucellosis Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Brucellosis Vaccines Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Brucellosis Vaccines Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Brucellosis Vaccines Production, (2021-2026) & (M Doses)
Table 41. China Based Manufacturers Brucellosis Vaccines Production Market Share (2021-2026)
Table 42. Rest of World Based Brucellosis Vaccines Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Brucellosis Vaccines Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Brucellosis Vaccines Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Brucellosis Vaccines Production, (2021-2026) & (M Doses)
Table 46. Rest of World Based Manufacturers Brucellosis Vaccines Production Market Share (2021-2026)
Table 47. World Brucellosis Vaccines Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Brucellosis Vaccines Production by Type (2021-2026) & (M Doses)
Table 49. World Brucellosis Vaccines Production by Type (2027-2032) & (M Doses)
Table 50. World Brucellosis Vaccines Production Value by Type (2021-2026) & (USD Million)
Table 51. World Brucellosis Vaccines Production Value by Type (2027-2032) & (USD Million)
Table 52. World Brucellosis Vaccines Average Price by Type (2021-2026) & (USD/K Doses)
Table 53. World Brucellosis Vaccines Average Price by Type (2027-2032) & (USD/K Doses)
Table 54. World Brucellosis Vaccines Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Brucellosis Vaccines Production by Application (2021-2026) & (M Doses)
Table 56. World Brucellosis Vaccines Production by Application (2027-2032) & (M Doses)
Table 57. World Brucellosis Vaccines Production Value by Application (2021-2026) & (USD Million)
Table 58. World Brucellosis Vaccines Production Value by Application (2027-2032) & (USD Million)
Table 59. World Brucellosis Vaccines Average Price by Application (2021-2026) & (USD/K Doses)
Table 60. World Brucellosis Vaccines Average Price by Application (2027-2032) & (USD/K Doses)
Table 61. Jinyu Basic Information, Manufacturing Base and Competitors
Table 62. Jinyu Major Business
Table 63. Jinyu Brucellosis Vaccines Product and Services
Table 64. Jinyu Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Jinyu Recent Developments/Updates
Table 66. Jinyu Competitive Strengths & Weaknesses
Table 67. Colorado Serum Basic Information, Manufacturing Base and Competitors
Table 68. Colorado Serum Major Business
Table 69. Colorado Serum Brucellosis Vaccines Product and Services
Table 70. Colorado Serum Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Colorado Serum Recent Developments/Updates
Table 72. Colorado Serum Competitive Strengths & Weaknesses
Table 73. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 74. Boehringer Ingelheim Major Business
Table 75. Boehringer Ingelheim Brucellosis Vaccines Product and Services
Table 76. Boehringer Ingelheim Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Boehringer Ingelheim Recent Developments/Updates
Table 78. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 79. Biogenesis-Bago Basic Information, Manufacturing Base and Competitors
Table 80. Biogenesis-Bago Major Business
Table 81. Biogenesis-Bago Brucellosis Vaccines Product and Services
Table 82. Biogenesis-Bago Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Biogenesis-Bago Recent Developments/Updates
Table 84. Biogenesis-Bago Competitive Strengths & Weaknesses
Table 85. Vetal Company Basic Information, Manufacturing Base and Competitors
Table 86. Vetal Company Major Business
Table 87. Vetal Company Brucellosis Vaccines Product and Services
Table 88. Vetal Company Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Vetal Company Recent Developments/Updates
Table 90. Vetal Company Competitive Strengths & Weaknesses
Table 91. CZ Veterinaria Basic Information, Manufacturing Base and Competitors
Table 92. CZ Veterinaria Major Business
Table 93. CZ Veterinaria Brucellosis Vaccines Product and Services
Table 94. CZ Veterinaria Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. CZ Veterinaria Recent Developments/Updates
Table 96. CZ Veterinaria Competitive Strengths & Weaknesses
Table 97. SYVA Laboratorios Basic Information, Manufacturing Base and Competitors
Table 98. SYVA Laboratorios Major Business
Table 99. SYVA Laboratorios Brucellosis Vaccines Product and Services
Table 100. SYVA Laboratorios Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. SYVA Laboratorios Recent Developments/Updates
Table 102. SYVA Laboratorios Competitive Strengths & Weaknesses
Table 103. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 104. Indian Immunologicals Major Business
Table 105. Indian Immunologicals Brucellosis Vaccines Product and Services
Table 106. Indian Immunologicals Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Indian Immunologicals Recent Developments/Updates
Table 108. Indian Immunologicals Competitive Strengths & Weaknesses
Table 109. Qilu Basic Information, Manufacturing Base and Competitors
Table 110. Qilu Major Business
Table 111. Qilu Brucellosis Vaccines Product and Services
Table 112. Qilu Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Qilu Recent Developments/Updates
Table 114. Qilu Competitive Strengths & Weaknesses
Table 115. Tecnovax Basic Information, Manufacturing Base and Competitors
Table 116. Tecnovax Major Business
Table 117. Tecnovax Brucellosis Vaccines Product and Services
Table 118. Tecnovax Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Tecnovax Recent Developments/Updates
Table 120. Tecnovax Competitive Strengths & Weaknesses
Table 121. Hester Biosciences Basic Information, Manufacturing Base and Competitors
Table 122. Hester Biosciences Major Business
Table 123. Hester Biosciences Brucellosis Vaccines Product and Services
Table 124. Hester Biosciences Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Hester Biosciences Recent Developments/Updates
Table 126. Hester Biosciences Competitive Strengths & Weaknesses
Table 127. Zoetis Basic Information, Manufacturing Base and Competitors
Table 128. Zoetis Major Business
Table 129. Zoetis Brucellosis Vaccines Product and Services
Table 130. Zoetis Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Zoetis Recent Developments/Updates
Table 132. Zoetis Competitive Strengths & Weaknesses
Table 133. Onderstepoort Biological Basic Information, Manufacturing Base and Competitors
Table 134. Onderstepoort Biological Major Business
Table 135. Onderstepoort Biological Brucellosis Vaccines Product and Services
Table 136. Onderstepoort Biological Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. Onderstepoort Biological Recent Developments/Updates
Table 138. Onderstepoort Biological Competitive Strengths & Weaknesses
Table 139. Instituto Rosenbusch Basic Information, Manufacturing Base and Competitors
Table 140. Instituto Rosenbusch Major Business
Table 141. Instituto Rosenbusch Brucellosis Vaccines Product and Services
Table 142. Instituto Rosenbusch Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Instituto Rosenbusch Recent Developments/Updates
Table 144. Instituto Rosenbusch Competitive Strengths & Weaknesses
Table 145. Ceva Sante Animale Basic Information, Manufacturing Base and Competitors
Table 146. Ceva Sante Animale Major Business
Table 147. Ceva Sante Animale Brucellosis Vaccines Product and Services
Table 148. Ceva Sante Animale Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 149. Ceva Sante Animale Recent Developments/Updates
Table 150. Ceva Sante Animale Competitive Strengths & Weaknesses
Table 151. Calier & Biologicos Laverlam Basic Information, Manufacturing Base and Competitors
Table 152. Calier & Biologicos Laverlam Major Business
Table 153. Calier & Biologicos Laverlam Brucellosis Vaccines Product and Services
Table 154. Calier & Biologicos Laverlam Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Calier & Biologicos Laverlam Recent Developments/Updates
Table 156. Calier & Biologicos Laverlam Competitive Strengths & Weaknesses
Table 157. Biovet Basic Information, Manufacturing Base and Competitors
Table 158. Biovet Major Business
Table 159. Biovet Brucellosis Vaccines Product and Services
Table 160. Biovet Brucellosis Vaccines Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 161. Biovet Recent Developments/Updates
Table 162. Biovet Competitive Strengths & Weaknesses
Table 163. Global Key Players of Brucellosis Vaccines Upstream (Raw Materials)
Table 164. Global Brucellosis Vaccines Typical Customers
Table 165. Brucellosis Vaccines Typical Distributors

LIST OF FIGURES

Figure 1. Brucellosis Vaccines Picture
Figure 2. World Brucellosis Vaccines Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Brucellosis Vaccines Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Brucellosis Vaccines Production (2021-2032) & (M Doses)
Figure 5. World Brucellosis Vaccines Average Price (2021-2032) & (USD/K Doses)
Figure 6. World Brucellosis Vaccines Production Value Market Share by Region (2021-2032)
Figure 7. World Brucellosis Vaccines Production Market Share by Region (2021-2032)
Figure 8. North America Brucellosis Vaccines Production (2021-2032) & (M Doses)
Figure 9. Europe Brucellosis Vaccines Production (2021-2032) & (M Doses)
Figure 10. China Brucellosis Vaccines Production (2021-2032) & (M Doses)
Figure 11. Japan Brucellosis Vaccines Production (2021-2032) & (M Doses)
Figure 12. India Brucellosis Vaccines Production (2021-2032) & (M Doses)
Figure 13. South America Brucellosis Vaccines Production (2021-2032) & (M Doses)
Figure 14. Brucellosis Vaccines Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Brucellosis Vaccines Consumption (2021-2032) & (M Doses)
Figure 17. World Brucellosis Vaccines Consumption Market Share by Region (2021-2032)
Figure 18. United States Brucellosis Vaccines Consumption (2021-2032) & (M Doses)
Figure 19. China Brucellosis Vaccines Consumption (2021-2032) & (M Doses)
Figure 20. Europe Brucellosis Vaccines Consumption (2021-2032) & (M Doses)
Figure 21. Japan Brucellosis Vaccines Consumption (2021-2032) & (M Doses)
Figure 22. South Korea Brucellosis Vaccines Consumption (2021-2032) & (M Doses)
Figure 23. ASEAN Brucellosis Vaccines Consumption (2021-2032) & (M Doses)
Figure 24. India Brucellosis Vaccines Consumption (2021-2032) & (M Doses)
Figure 25. Producer Shipments of Brucellosis Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Brucellosis Vaccines Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Brucellosis Vaccines Markets in 2025
Figure 28. United States VS China: Brucellosis Vaccines Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Brucellosis Vaccines Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Brucellosis Vaccines Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Brucellosis Vaccines Production Market Share 2025
Figure 32. China Based Manufacturers Brucellosis Vaccines Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Brucellosis Vaccines Production Market Share 2025
Figure 34. World Brucellosis Vaccines Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Brucellosis Vaccines Production Value Market Share by Type in 2025
Figure 36. S19 Vaccine
Figure 37. RB51 Vaccine Strain
Figure 38. World Brucellosis Vaccines Production Market Share by Type (2021-2032)
Figure 39. World Brucellosis Vaccines Production Value Market Share by Type (2021-2032)
Figure 40. World Brucellosis Vaccines Average Price by Type (2021-2032) & (USD/K Doses)
Figure 41. World Brucellosis Vaccines Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 42. World Brucellosis Vaccines Production Value Market Share by Application in 2025
Figure 43. Cattle
Figure 44. Sheep
Figure 45. Others
Figure 46. World Brucellosis Vaccines Production Market Share by Application (2021-2032)
Figure 47. World Brucellosis Vaccines Production Value Market Share by Application (2021-2032)
Figure 48. World Brucellosis Vaccines Average Price by Application (2021-2032) & (USD/K Doses)
Figure 49. Brucellosis Vaccines Industry Chain
Figure 50. Brucellosis Vaccines Procurement Model
Figure 51. Brucellosis Vaccines Sales Model
Figure 52. Brucellosis Vaccines Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source


More Publications